search icon
  • Print
  • ShareThis
  • Text Size
  • HIVMA News Release
  • HIVMA Applauds Start of AIDS 2012 Conference


    Important week of research discoveries, advocacy, and collaboration ahead

    WASHINGTON, D.C.—As AIDS 2012 gets under way in Washington, D.C., this week, the HIV Medicine Association (HIVMA) is thrilled to be a part of this important conference as it marks its return to the U.S. for the first time in more than 20 years.

    “As a local scientific partner, along with the National Institutes of Health (NIH), HIVMA worked with the International AIDS Society, NIH, and other partners to create a program showcasing the latest HIV-related science and highlighting how it can improve prevention and health outcomes on the frontlines,” said HIVMA Chair Judith A. Aberg, MD, FIDSA. “Armed with the latest discoveries and a renewed commitment to the fight against this disease, we can begin to turn the tide and achieve the goal of an AIDS-free generation here in the U.S. and around the world.”

    In addition to encouraging HIVMA members and their colleagues to participate in the conference by submitting research, HIVMA also awarded 16 travel grants to fellows or residents in training in the U.S. who had abstracts accepted to AIDS 2012, helping to foster the next generation of HIV clinicians and researchers.

    On the eve of AIDS 2012, with the spotlight on the AIDS pandemic in the U.S. capital, HIVMA honored four heroes in the long-running fight against AIDS—U.S. Reps. Henry Waxman and Barbara Lee, advocate Mary Fisher, and journalist Lawrence Altman, MD—to recognize that the great progress to date in fighting HIV would not have been possible without the leadership, commitment, and passion of advocates, people living with HIV, policymakers, and journalists.

    With the conference now under way, HIVMA, with its Center for Global Health Policy, will kick off three days of interactive programming in the AIDS 2012 Global Village. “Community and Science Speak” will bring together researchers and civil society representatives to bridge the gap between science, policy, and practice. Presenters will explore the science and implementation efforts, new and combination prevention interventions, HIV and tuberculosis co-infection, marginalized populations, and other topics. (The full schedule is online:

    On Tuesday evening, July 24, a diverse group of stakeholders from the domestic and global communities will discuss the latest science on HIV treatment as prevention and identify challenges and opportunities for implementing it on a larger scale. Co-sponsored by HIVMA, the Center for Global Health Policy, and the American Association for the Advancement of Science (AAAS), “Treatment as Prevention: From Science to Implementation” will take place at the AAAS Auditorium at 1200 New York Avenue, NW, in Washington, D.C. (The symposium lineup is available online:

    Throughout AIDS 2012, Science Speaks (, the blog of the Center for Global Health Policy, will also provide live coverage of the research advances unveiled at the conference, plus responses and perspectives from those most affected and involved.

    “This conference will offer an unprecedented opportunity to share new HIV research and knowledge and renew the world’s commitment to fighting this epidemic,” Dr. Aberg said. “We couldn’t be more excited to be a part of AIDS 2012 and to see it off to such a wonderful start.”

  • The HIV Medicine Association (HIVMA) is the professional home for more than 5,000 physicians, scientists, and other health care professionals dedicated to the field of HIV/AIDS. Nested within the Infectious Diseases Society of America (IDSA), HIVMA promotes quality in HIV care and advocates policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice. For more information, visit

| IDSA | Contact Us

© Copyright HIVMA 2018 HIV Medicine Association

Full Site Mobile Site